WallStSmart

Garmin Ltd (GRMN)vsMesa Laboratories Inc (MLAB)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Garmin Ltd generates 2827% more annual revenue ($7.25B vs $247.54M). GRMN leads profitability with a 23.0% profit margin vs 1.5%. GRMN trades at a lower P/E of 28.1x. GRMN earns a higher WallStSmart Score of 61/100 (C+).

GRMN

Buy

61

out of 100

Grade: C+

Growth: 8.0Profit: 8.5Value: 7.3Quality: 9.0
Piotroski: 5/9Altman Z: 5.27

MLAB

Hold

38

out of 100

Grade: F

Growth: 4.0Profit: 4.5Value: 3.0Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

GRMNUndervalued (+40.9%)

Margin of Safety

+40.9%

Fair Value

$349.38

Current Price

$244.78

$104.60 discount

UndervaluedFair: $349.38Overvalued
MLABSignificantly Overvalued (-1964.0%)

Margin of Safety

-1964.0%

Fair Value

$4.42

Current Price

$83.60

$79.18 premium

UndervaluedFair: $4.42Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

GRMN6 strengths · Avg: 8.8/10
Debt/EquityHealth
0.0210/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
5.2710/10

Safe zone — low bankruptcy risk

Profit MarginProfitability
23.0%9/10

Keeps 23 of every $100 in revenue as profit

Operating MarginProfitability
28.9%8/10

Strong operational efficiency at 28.9%

Revenue GrowthGrowth
16.6%8/10

16.6% revenue growth

EPS GrowthGrowth
21.2%8/10

Earnings expanding 21.2% YoY

MLAB1 strengths · Avg: 8.0/10
Price/BookValuation
2.5x8/10

Reasonable price relative to book value

Areas to Watch

GRMN2 concerns · Avg: 3.0/10
P/E RatioValuation
28.1x4/10

Moderate valuation

PEG RatioValuation
3.132/10

Expensive relative to growth rate

MLAB4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
3.6%4/10

3.6% revenue growth

Market CapQuality
$455.25M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
2.2%3/10

ROE of 2.2% — below average capital efficiency

Profit MarginProfitability
1.5%3/10

1.5% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : GRMN

The strongest argument for GRMN centers on Debt/Equity, Altman Z-Score, Profit Margin. Profitability is solid with margins at 23.0% and operating margin at 28.9%. Revenue growth of 16.6% demonstrates continued momentum.

Bull Case : MLAB

The strongest argument for MLAB centers on Price/Book.

Bear Case : GRMN

The primary concerns for GRMN are P/E Ratio, PEG Ratio.

Bear Case : MLAB

The primary concerns for MLAB are Revenue Growth, Market Cap, Return on Equity. A P/E of 126.8x leaves little room for execution misses. Thin 1.5% margins leave little buffer for downturns.

Key Dynamics to Monitor

GRMN profiles as a growth stock while MLAB is a value play — different risk/reward profiles.

GRMN carries more volatility with a beta of 0.95 — expect wider price swings.

GRMN is growing revenue faster at 16.6% — sustainability is the question.

GRMN generates stronger free cash flow (430M), providing more financial flexibility.

Bottom Line

GRMN scores higher overall (61/100 vs 38/100), backed by strong 23.0% margins and 16.6% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Garmin Ltd

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

Garmin Ltd. is an American multinational technology company with headquarters in Olathe, Kansas.

Visit Website →

Mesa Laboratories Inc

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products in the United States, Europe, Asia, North America, and internationally. The company is headquartered in Lakewood, Colorado.

Want to dig deeper into these stocks?